To determine the role of MMP-13/PD-1H in the development of myeloma-induced lytic bone lesions, we developed an intratibial MM bone disease model using Pd-1hwtRag2-/- mice that recapitulates myeloma tumor growth coupled with severe osteolysis3. Here, MMP13 is linked to plasma cell myeloma.